Search

everythinglearnresearchcommunity

for

Search:↓

Certain medications including flutamide, spironolactone, and others effectively reduce excessive hair growth in women, especially when combined with lifestyle changes.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Antiandrogens, particularly flutamide and CPA, are most effective for treating hirsutism, with long-term use needed for best results.

Finasteride and spironolactone both reduce hirsutism, but finasteride lowers androgen levels more.

Spironolactone reduces the enzyme activity that converts testosterone to DHT, helping treat excessive hair growth in women.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Spironolactone is better than placebo for reducing excessive hair growth in women, but its effectiveness for acne is unclear due to small study sizes.

The document concludes that managing hirsutism involves identifying the cause, using a scoring system for severity, combining cosmetic and medical treatments, encouraging weight loss, and providing psychological support, while noting the need for more research on drug treatments.

Some medications can reduce excessive hair growth in women, but more research is needed to find the best treatment combinations.

Flutamide combined with a low-dose birth control pill effectively reduces excessive hair growth in women with polycystic ovarian disease.

The document concludes that careful evaluation is needed to diagnose PCOS correctly due to similar symptoms in other conditions, and accurate testosterone level measurement is crucial.

Eating less starch and dairy helped overweight women with PCOS lose weight and improve symptoms.

Prostate-specific antigen may be a new marker for excess male hormones in women with polycystic ovary syndrome.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Testosterone increases hair growth and acne in transgender men.

Excessive hair growth is much more common in Chinese women with PCOS than in the general population.

Women with PCOS have lower amylin levels, which are not related to their body weight.

The conclusion is that proper diagnosis and long-term treatment, including medication, hair removal, and lifestyle changes, are important for improving hirsutism, especially in PCOS patients.

The photographic method accurately measures hair growth and both treatments effectively reduced hair growth in hirsute women.

Cheap treatments for excessive hair growth in women can improve symptoms by 35-40% after one year.

An unusual growth of Leydig cells in a woman's ovaries caused her excessive hair growth, which was treated successfully with surgery.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Flutamide worked better than finasteride for reducing excessive hair growth in women, but had more side effects.

Hirsute women with ovarian-sourced hirsutism are more likely to have irregular periods, with higher BMI and altered hormone ratios.

Spironolactone is effective for idiopathic hirsutism but has limited effects on other PCOS symptoms.

Metformin improves hair growth and menstrual frequency in women with PCOS and hirsutism.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Most hirsutism patients had idiopathic hirsutism or PCOS, with hormonal imbalances and signs like acne and irregular periods.

The document concludes that managing hirsutism in PCOS involves long-term treatment guided by severity, using oral contraceptives and possibly antiandrogens, with attention to individual patient needs.